Skip to content
Search

Latest Stories

Mahendra Patel spearheads historic partnership in Northern Ireland

Mahendra Patel spearheads historic partnership in Northern Ireland

The partnership aims to improve health outcomes and reduce disparities through collaborative research

The University of Oxford's Centre for Research Equity (CfRE) has entered into a historic partnership with key health and social care agencies in Northern Ireland to advance health equity across the region and ensure everyone benefits from healthcare advancements.


Unveiled during an event at Parliament Buildings in Stormont Estate on Wednesday, this groundbreaking partnership makes Northern Ireland the first UK region to partner with CfRE.

The partnership, involving the Health and Social Care Research and Development (HSC R&D) Division in Northern Ireland, the Department of Health Northern Ireland, and other key health and social care agencies, aims to improve health outcomes and reduce disparities through collaborative research.

Northern Ireland's Health Minister, Mike Nesbitt, highlighted that this new partnership represents “a significant step forward in efforts to address health inequalities” in the region.

“By bringing together leading experts and resources from across sectors, we can work towards conducting research that truly benefits all of our communities,” he said.

Professor Mahendra G Patel, Director of CfRE, emphasised the partnership's commitment to community engagement, stating: "At the heart of this ground-breaking partnership between Oxford University and Northern Ireland is a dedication to involving patients, the public, underserved communities, as well as health and care organisations and stakeholders in setting research priorities.”

He added: “We want to ensure that research outcomes are applicable, safe and beneficial to all, and that starts with listening to and engaging with the very people we serve, including those who are often disproportionately affected by poorer health and health outcomes.”

Laura Collins, Lived Experience Expert (Family Carer), and Public Involvement Enhancing Research (PIER) group member, HSC Research & Development Division, Public Health Agency, and a full-time family carer for the past 43 years, underscored the significance of research equity for patients and carers.

"As someone who has spent decades advocating for family carers and individuals with disabilities, I know firsthand how crucial it is for research to reflect the needs and experiences of all communities.

“The partnership's commitment to involving all in research is a vital step towards ensuring that everyone can benefit from advances in healthcare,” she said.

Professor Cathy Harrison, Chief Pharmaceutical Officer in Northern Ireland, noted that this initiative builds on the lessons learned and relationships forged during the COVID-19 pandemic.

She added that they are committed to developing new collaborative approaches that will ensure that research reaches and includes diverse populations, including those who have been “historically underrepresented” or “faced barriers to accessing research opportunities.”

Professor Ian Young, Chief Scientific Advisor at the Northern Ireland Department of Health, highlighted that this new partnership brings together various sectors in Northern Ireland, including health and social care, academia, industry, and the voluntary sector, to leverage collective strengths.

Dr. Janice Bailie, Assistant Director at HSC R&D Division, pointed out that this collaboration reflects their dedicated effort to incorporate the perspectives of diverse communities into their research framework and ensure inclusivity.

Professor Richard Hobbs, Pro-Vice Chancellor of the University of Oxford, noted that this partnership is not a one-time initiative, but rather “a long-term commitment to advancing research equity and improving health outcomes in Northern Ireland and beyond.”

“By building a strong foundation of collaboration and community engagement, we aim to create lasting change,” he said.

This initiative is part of CfRE's broader strategy to establish multiple hubs across the UK, to aimed at building a healthier and more inclusive future for all.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less